Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
12 hedge funds and large institutions have $742K invested in Yield10 Bioscience, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
8% less funds holding
Funds holding: 13 → 12 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
53% less capital invested
Capital invested by funds: $1.58M → $742K (-$842K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$18.3K |
| 2 |
VF
Virtu Financial
New York
|
+$18.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$4.88K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$2.44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Birchview Capital
Burlington,
Vermont
|
-$189K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$68K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$33K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$20.8K |
| 5 |
GC
GMT Capital
Atlanta,
Georgia
|
-$3.66K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $341K | +$18.3K | +15 | +4% |
|
|
BC
2
Birchview Capital
Burlington,
Vermont
| $97K | -$189K | -155 | -55% |
|
|
CC
3
Cannell & Co
New York
| $97K | – | – | – |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $86K | – | – | – |
|
5
Geode Capital Management
Boston,
Massachusetts
| $45K | – | – | – |
|
|
GC
6
GMT Capital
Atlanta,
Georgia
| $26K | -$3.66K | -3 | -9% |
|
7
BlackRock
New York
| $12K | – | – | – |
|
|
VF
8
Virtu Financial
New York
| $12K | +$18.3K | +15 | New |
|
|
9
Citadel Advisors
Miami,
Florida
| $10K | -$20.8K | -17 | -57% |
|
|
TSS
10
Two Sigma Securities
New York
| $10K | +$2.44K | +2 | +18% |
|
|
WF
11
WealthTrust Fairport
Cleveland,
Ohio
| $3K | – | – | – |
|
|
12
UBS Group
Zurich,
Switzerland
| $3K | +$4.88K | +4 | New |
|
|
APA
13
American Portfolios Advisors
Holbrook,
New York
| $13 | – | – | – |
|
|
SM
14
Sabby Management
Miami Beach,
Florida
| – | -$68K | -50 | Closed |
|
|
15
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$33K | -24 | Closed |
|
16
Bank of America
Charlotte,
North Carolina
| – | -$3K | -2 | Closed |
|
YTEN Hedge Fund Activity: Q4 2018 in Review
12 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q4 2018, worth a combined $742K — down 53% from $1.58M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of YTEN and 2 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 2 added.
The largest buyer was Renaissance Technologies, adding an estimated $18.3K. The largest seller was Birchview Capital, cutting an estimated $189K.
- 12 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q4 2018, down from 13 in Q3 2018.
- Funds reported $742K of Yield10 Bioscience, Inc. Common Stock stock for Q4 2018, down 53% quarter-over-quarter.
- 2 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q4 2018 and 3 closed out, a net change of -1 holder.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q4 2018 was Renaissance Technologies, an estimated $18.3K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q4 2018 was Birchview Capital, an estimated $189K sold.
Based on aggregated 13F filings for Q4 2018.